This year’s ASH, as we all know, has been very different, thanks to Covid-19. We’ve missed lots of things by not being physically together; however, there are always silver linings! I’m mostly grateful to the resilient researchers, hematologists/oncologists, nurses, and pharmaceutical companies that have keep research going through this pandemic. While there were fewer abstracts at ASH this […]